INC.;SYNDAX PHARMACEUTICALS;SYNDAX PHARMACEUTICALS, INC.;MERCK PATENT GMBH;PFIZER INC.
发明人:
ORDENTLICH, PETER,MEYERS, MICHEL
申请号：
CA3004369
公开号：
CA3004369A1
申请日:
2016.12.28
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Described herein are methods for the treatment of heavily pre-treated recurrent ovarian cancer. In particular, methods are provided for the treatment of heavily pre-treated recurrent ovarian cancer with a combination of entinostat and an anti-PD-L1 antibody.
